Browsing by Author Pinese, Mark

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 17 of 17
Issue DateTitleAuthor(s)Citation
2014Adjuvant chemotherapy in elderly patients with pancreatic cancerGill, Anthony; Kench, James; Australian Pancreatic Cancer Genome Initiative, A; Biankin, Andrew V.; Chang, David K.; Chantrill, Lorraine; Chin, Venessa; Chou, Angela; Colvin, Emily; Horvath, Lisa; Humphris, Jeremy; Johns, Amber; Nagrial, Adnan; Nguyen, Nam Q; Pajic, Marina; Pinese, Mark; Samra, JS; Scarlett, Christopher; Sutherland, Robert L.; Deans Unit: (CIPHER); School of Medical Sciences: PathologyAdjuvant chemotherapy in elderly patients with pancreatic cancer, British Journal of Cancer, vol.110, 2, 2014,pp 313-319
2009BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breastMcNeil, Catriona; O'Toole, Sandra; Anderson, Luke R.; Biankin, Andrew V.; Butt, Alison Joy; Crea, P; Henshall, Susan M.; Millar, E.; Morey, Adrienne; Musgrove, Elizabeth A.; Pinese, Mark; Sutherland, Robert L.; Western Clinical School: Medicine (Westmead); Central Clinical School: PathologyBAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast, British Journal of Cancer, vol.100, 1,pp 123-133
2013Clinical and molecular characterization of HER2 amplified-pancreatic cancerGill, Anthony; Toon, Christopher; Biankin, Andrew V.; Chang, David K.; Chantrill, Lorraine; Chin, Venessa; Chou, Angela; Cowley, Mark; Goldstein, David; Grimmond, Sean Michael; Humphris, Jeremy; Johns, Amber; Kassahn, Karin; Mead, Scott; Miller, David K; Morey, Adrienne; Musgrove, Elizabeth A.; Nagrial, Adnan; Nones, Katia; Pajic, Marina; Patch, Anne-Marie; Pearson, John V; Pinese, Mark; Rooman, Ilse; Samra, JS; Waddell, Nic; Wasan, Harpreet; Wu, Jianmin; Deans Unit: (CIPHER); Northern Clinical School: Kolling InstituteClinical and molecular characterization of HER2 amplified-pancreatic cancer, Genome Medicine, vol.5, 8, 2013,pp 1-11
2014Clinical and pathologic features of familial pancreatic cancerGill, Anthony; Kench, James; Samra, Jaswinder; Chang, David K.; Chantrill, Lorraine; Chin, Venessa; Cowley, Mark; et al, Various; Humphris, Jeremy; Johns, Amber L; Mead, Scott; Nagrial, Adnan; Pajic, Marina; Pinese, Mark; Simpson, Skye H; Northern Clinical School: Pathology; School of Medical Sciences: Pathology; Northern Clinical School: SurgeryClinical and pathologic features of familial pancreatic cancer, Cancer, vol.120, 23, 2014,pp 3669-3675
2016Defining the genetic basis of early onset hereditary spastic paraplegia using whole genome sequencingKumar, Kishore Raj; Roscioli, Tony; Sue, Carolyn; Wali, Gautam; Cowley, Mark; Dinger, Marcel; Gayevskiy, Velimir; Kamate, Mahesh; Minoche, Andre; Pinese, Mark; Puttick, Clare; Wali, G. M.; Northern Clinical School: Kolling Institute; Central Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: Kolling InstituteDefining the genetic basis of early onset hereditary spastic paraplegia using whole genome sequencing, Neurogenetics, vol.17, 4, 2016,pp 265-270
2007The Effect of Resveratrol on a Cell Model of Human AgingMarkus, Marietta (Andrea); Morris, Brian; Stefani, Maurizio; Dawes, Ian W.; Lin, Ruby C. Y.; Pinese, Mark; School of Medical Sciences: Physiology; School of Medical Sciences: Physiology; School of Medical Sciences: PhysiologyThe Effect of Resveratrol on a Cell Model of Human Aging, Annals of New York Academy of Sciences, vol.1114,(N/A),2007,pp 407-418
2009Expression of S100A2 Calcium-Binding Protein Predicts Response to Pancreatectomy for Pancreatic CancerKench, James; Lee, Cheok; Biankin, Andrew; Chang, David K.; Colvin, E K; Cosman, P H; et al, Various; Kuo, Samuel; Morey, Adrienne; Nguyen, Nam; Pinese, Mark; Scarlett, Christopher; Segara, Davendra; Susanto, J; School of Medical Sciences: Pathology; Central Clinical School: MedicineExpression of S100A2 Calcium-Binding Protein Predicts Response to Pancreatectomy for Pancreatic Cancer, Gastroenterology, vol.137, 2, 2009,pp 558-568
2010High Notch1 protein expression is an early event in breast cancer development and is associated with the HER-2 molecular subtypeHamilton, Anne; Lee, Cheok; McNeil, Catriona; Spillane, Andrew; Crea, P; Lopez-Knowles, Elena; McLeod, Duncan; Millar, Ewan; Morey, Adrienne; Murphy, N C; Musgrove, Elizabeth A.; Oakes, Samantha; Ormandy, Christopher J.; O'Toole, Sandra; Pinese, Mark; Qiu, Min; Sutherland, Robert L.; Zardawi, Ibrahim; Zardawi, Sarah J; Central Clinical School: Medicine; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead); Northern Clinical School: MedicineHigh Notch1 protein expression is an early event in breast cancer development and is associated with the HER-2 molecular subtype, Histopathology, vol.56, 3,pp 286-296
2013Histomolecular Phenotypes and Outcome in Adenocarcinoma of the Ampulla of VaterGill, Anthony; Kench, James; Samra, Jaswinder; Chang, David K.; Chantrill, Lorraine; Chou, Angela; et al, Various; Humphris, Jeremy; Jamieson, Nigel; Johns, Amber; Jones, Marc; Nagrial, Adnan; Pajic, Marina; Pinese, Mark; Scarlett, Christopher; Toon, Christopher; Northern Clinical School: Pathology; School of Medical Sciences: Pathology; Northern Clinical School: SurgeryHistomolecular Phenotypes and Outcome in Adenocarcinoma of the Ampulla of Vater, Journal of Clinical Oncology, vol.31, 10, 2013,pp 1348-1356
2011Identification of PUMA as an estrogen target gene that mediates the apoptotic response to tamoxifen in human breast cancer cells and predicts patient outcome and tamoxifen responsiveness in breast cancerMcNeil, Catriona; O'Toole, Sandra; Butt, Alison Joy; Lehrbach, Gillian M.; McCloy, R. A.; Millar, E. K. A.; Musgrove, Elizabeth A.; Pinese, Mark; Roberts, C. G.; Sutherland, Robert L.; Tobelmann, P; Western Clinical School: Medicine (Westmead); Central Clinical School: PathologyIdentification of PUMA as an estrogen target gene that mediates the apoptotic response to tamoxifen in human breast cancer cells and predicts patient outcome and tamoxifen responsiveness in breast cancer, Oncogene: including Oncogene Reviews, vol.30, 28, 2011,pp 3186-3197
2017Lost in translation: Returning germline genetic results in genome-scale cancer researchGill, Anthony; Pavlakis, Nick; Andrews, L.; Chantrill, Lorraine; et al, Various; Goodwin, Annabel; Humphris, Jeremy; Johns, Amber; Leonard, C; McKay, Skye; Mead, Scott; Pinese, Mark; Samra, Jaswinder S; Tucker, Katherine M.; Northern Clinical School: Pathology; Northern Clinical School: MedicineLost in translation: Returning germline genetic results in genome-scale cancer research, Genome Medicine, vol.9, 1, 2017,pp 1-9
2009Messina: A Novel Analysis Tool to Identify Biologically Relevant Molecules in DiseaseKench, James; Biankin, Andrew V.; Colvin, E K; Henshall, Susan M.; Pinese, Mark; Scarlett, C J; Segara, Davendra; Sutherland, Robert L.; School of Medical Sciences: PathologyMessina: A Novel Analysis Tool to Identify Biologically Relevant Molecules in Disease, PLoS One, vol.4, 4, 2009,pp e5337-1-e5337-7
2014Profiling the tyrosine phosphoproteome of different mouse mammary tumour models reveals distinct, model-specific signalling networks and conserved oncogenic pathwaysArmstrong, Nicola Joy; Ali, Naveid; Chan, Howard; Clark, S; Daly, Roger; Hochgrafe, Falko; Lee, Hongching; Lyons, Ruth J.; Nair, Radhika; Ormandy, Christopher J.; Pinese, Mark; Swarbrick, A.; Wu, Jianmin; Ye, S; Zhang, Luxi; Mathematics & StatisticsProfiling the tyrosine phosphoproteome of different mouse mammary tumour models reveals distinct, model-specific signalling networks and conserved oncogenic pathways, Breast Cancer Research, vol.16, 5, 2014,pp 1-19
2012qpure: A Tool to Estimate Tumor Cellularity from Genome-Wide Single-Nucleotide Polymorphism ProfilesGill, Anthony; Anderson, Matthew; et al, Various; Harliwong, Ivon; Holmes, Oliver; Johns, Amber; Kassahn, Karin; Miller, David; Nones, Katia; Pajic, Marina; Pinese, Mark; Song, Sarah; Northern Clinical School: Pathologyqpure: A Tool to Estimate Tumor Cellularity from Genome-Wide Single-Nucleotide Polymorphism Profiles, PLoS One, vol.7, 9, 2012,pp 1-7
2011Retinoid signaling in pancreatic cancer, injury and regenerationKench, James; O'Toole, Sandra; Apte, M V; Biankin, Andrew; Chang, David K.; Colvin, E K; Mawson, Amanda; Musgrove, Elizabeth A.; Ong, Vivienna N; Pinese, Mark; Rooman, Ilse; Scarlett, C J; Segara, Davendra; Susanto, J; Sutherland, Robert L.; School of Medical Sciences: Pathology; Central Clinical School: PathologyRetinoid signaling in pancreatic cancer, injury and regeneration, PLoS One, vol.6, 12, 2011,pp e29075 - 1-e29075 - 10
2013Somatic Point Mutation Calling in Low Cellularity TumorsGill, Anthony; Anderson, Matthew; Biankin, Andrew V.; Bruxner, Timothy; Chang, David K.; Christ, Angelika; Cowley, Mark; Fink, Lynn; Grimmond, Sean Michael; Harliwong, Ivon; Holmes, Oliver; Idrisoglu, Senel; Johns, Amber; Kassahn, Karin; Leonard, Conrad; Manning, Suzanne; Miller, David K; Newell, Felicity; Nones, Katia; Nourbakhsh, Eshan; Nourse, Craig; Pajic, Marina; Patch, Anne-Marie; Pearson, John V; Pinese, Mark; Song, Sarah; Steptoe, Anita; Taylor, Darrin; Waddell, Nicola; Wani, Shivangi; Wilson, Peter J; Wood, Scott; Wu, Jianmin; Xu, Qingying; Northern Clinical School: PathologySomatic Point Mutation Calling in Low Cellularity Tumors, PLoS One, vol.8, 11, 2013,pp 1-10
2015Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacyAu, Amy; et al, Various; Jamieson, Nigel B; Leach, Joshua; McGarry, Lynn; McGhee, Ewan; Miller, Bryan W; Morton, Jennifer; Pinese, Mark; Saturno, Grazia; Shanks, Emma; Timpson, Paul; Northern Clinical School: Kolling InstituteTargeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy, EMBO Molecular Medicine (Online), vol.7, 8, 2015,pp 1063-1076